A number of other conditions were examined in an effort
to improve the yield. Use of s-BuLi for deprotonation of
the oxaphosphetane intermediate 14 resulted in a slight
increase in yield (32%). Further improvement was achieved
(42%) when monomeric formaldehyde in ether solution was
used with s-BuLi12,13 as an alternative to use of paraform-
aldehyde. Subsequent experiments with monomeric formal-
dehyde and n-BuLi provided a lower yield (34%), thereby
suggesting that both the stronger base and the more reactive
form of formaldehyde were helpful.
Horner-Wadsworth-Emmons (HWE) reaction15 of the two
previously described ketones (13 and 18, respectively,
Scheme 5). Reaction of nerylacetone (18) with triethyl
Scheme 5. Synthesis of (2E,6Z)-Farnesol
Still other trials at different reaction temperature also were
performed in hopes of further improvement of the yield.
During the course of these experiments, the order of addition
for the geranylacetone and formaldehyde also was reversed.
Although in theory this strategy also could lead to farnesol
2, repeated examination of such conditions provided com-
plicated mixtures of unknown products and no apparent
formation of the desired isoprenoid 2.
To apply this methodology to preparation of (2Z,6Z)-
farnesol (3) required starting with ketone 18, nerylacetone
(Scheme 4). Although this ketone is commercially available
phosphonoacetate gave rise to the expected conjugated ester
19 where the C-2 olefin was formed primarily as the (E)-
isomer (10:1, E:Z). Standard reduction of ester 19 with
lithium aluminum hydride under mild conditions generated
alcohol 4 in 55% yield over 2 steps. Similarly, preparation
of commercial (2E,6E)-farnesol (2) also can be achieved via
a parallel route beginning with geranylacetone (13), which
may be an attractive means to obtain this isomer in greater
isomeric purity than the commercial material.16
Scheme 4. Synthesis of Nerylacetone and (2Z,2E)-Farnesol
Identification of the four geometric isomers of farnesol
was realized through use of 13C NMR data in comparison
with literature values.17 The 13C NMR spectra revealed
γ-effect differences for the C-2 olefin substituents of the
major and the minor olefin isomers from all four reaction
sequences. By chance there were striking similarities between
the 13C spectra of (2Z,6E)-farnesol (2) and (2E,6Z)-farnesol
(4), where the two olefins effectively mimic each other and
thus produce nearly identical spectra. However, in each case
the stereochemistry of the C-6 olefin was established by
choice of starting material, and the stereochemistry of the
C-2 olefin could be verified by HMBC experiments.12
Finally, it should be recognized that the methods described
here can be applied to the synthesis of other acyclic
isoprenoids. For example, when commercial (5E,9E)-farne-
sylacetone (20) was employed as the starting material
(Scheme 6), it was possible to prepare the corresponding
(2Z,6E,10E)-geranylgeraniol (21) using this modified Wittig
protocol, and (2E,6E,10E)-geranylgeraniol (22) was available
through the HWE strategy, both through short reaction
sequences in reasonable yields.7b Even though this was not
at considerable cost, it also can be prepared easily from neryl
bromide (16).14 Thus alkylation of ethyl acetoacetate with
bromide 16 followed by successive hydrolysis and decar-
boxylation of the resulting â-keto ester 17 afforded neryl-
acetone (18) in ∼60% yield over three steps. The synthesis
of farnesol 3 then was achieved in a 40% yield via a one-
flask reaction sequence under conditions parallel to those
used for preparation of compound 2. Again, the major
product was the (Z)-isomer, and this was readily separated
from the major byproduct resulting from formation of the
terminal olefin from compound 18.
Synthesis of the two other farnesol isomers, (2E,6Z)-
farnesol (4) and (2E,6E)-farnesol (2), could be based on a
(15) Coates, R. M.; Ley, D. A.; Cavender, P. L. J. Org. Chem. 1978,
43, 4915-4922.
(12) Representative experimental procedures and additional spectral data
are available in Supporting Information.
(13) Schlosser, M.; Jenny, T.; Guggisberg, Y. Synlett 1990, 11, 704.
(14) Kato, T.; Suzuki, M.; Kobayashi, T.; Moore, B. P. J. Org. Chem.
1980, 45, 1126-1130.
(16) Commercial trans,trans-farnesol contained only ∼70% of the desired
isomer via GC analysis.
(17) Burrell, J. W. K.; Garwood, R. F.; Jackman, L. M.; Oskay, E.;
Weedon, B. C. L. J. Chem. Soc. C 1966, 2144-2154.
Org. Lett., Vol. 7, No. 22, 2005
4805